Out-of-Pocket Spending Among Commercially Insured Patients for Epinephrine Autoinjectors Between 2007 and 2014

Kao-Ping Chua; Rena M Conti

doi:10.1001/jamainternmed.2017.0252

Out-of-Pocket Spending Among Commercially Insured Patients for Epinephrine Autoinjectors Between 2007 and 2014

JAMA Intern Med. 2017 May 1;177(5):736-739. doi: 10.1001/jamainternmed.2017.0252.

Authors

Kao-Ping Chua¹, Rena M Conti²

Affiliations

¹ Section of Academic Pediatrics, Department of Pediatrics, University of Chicago, Chicago, Illinois2Department of Public Health Sciences, University of Chicago, Chicago, Illinois.
² Department of Public Health Sciences, University of Chicago, Chicago, Illinois3Section of Pediatric Hematology/Oncology, Department of Pediatrics, University of Chicago, Chicago, Illinois.

Abstract

This study uses data from the Truven MarketScan Commercial Claims and Encounters database to track out-of-pocket spending among comercially insured patients for epinephrine autoinjectors between 2007 and 2014.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Anaphylaxis / economics*
Cost Savings / statistics & numerical data*
Cost of Illness
Epinephrine / administration & dosage
Epinephrine / economics*
Health Expenditures / statistics & numerical data*
Humans
Injections, Intramuscular / economics
Insurance Claim Review / statistics & numerical data
Medicaid / statistics & numerical data
United States

Substances

Epinephrine